In conclusion, we confirm the prognostic association of inflammatory markers TNFR-1, TNFR-2 and KIM-1 with kidney outcomes in individuals with type 2 diabetes and established CVD or at high cardiovascular risk. This evidence concerns the gene TNFRSF1B and type 2 diabetes mellitus.